Susceptibility genes in movement disorders
Identifieur interne : 001215 ( Istex/Corpus ); précédent : 001214; suivant : 001216Susceptibility genes in movement disorders
Auteurs : Sonja Scholz ; Andrew SingletonSource :
- Movement Disorders [ 0885-3185 ] ; 2008-05-15.
English descriptors
- KwdEn :
Abstract
During the last years, remarkable progress in our understanding of molecular genetic mechanisms underlying movement disorders has been achieved. The successes of linkage studies, followed by positional cloning, have dominated the last decade and several genes underlying monogenic disorders have been discovered. The pathobiological understanding garnered from these mutations has laid the foundation for much of the search for genetic loci that confer risk for, rather than cause, disease. With the introduction of whole genome association studies as a novel tool to investigate genetic variation underlying common, complex diseases, a new era in neurogenomics has just begun. As the field rapidly moves forward several new challenges and critical questions in clinical care have to be addressed. In this review, we summarize recent advances in the discovery of susceptibility loci underlying major movement disorders, explain the newest methodologies and tools employed for finding and characterizing genes and discuss how insights into the molecular genetic basis of neurological disorders will impact therapeutic concepts in patient care. © 2008 Movement Disorder Society
Url:
DOI: 10.1002/mds.21983
Links to Exploration step
ISTEX:410C307BA276A22DA15FD14937016AEFE50009F9Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Susceptibility genes in movement disorders</title><author><name sortKey="Scholz, Sonja" sort="Scholz, Sonja" uniqKey="Scholz S" first="Sonja" last="Scholz">Sonja Scholz</name><affiliation><mods:affiliation>Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square House, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Singleton, Andrew" sort="Singleton, Andrew" uniqKey="Singleton A" first="Andrew" last="Singleton">Andrew Singleton</name><affiliation><mods:affiliation>Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:410C307BA276A22DA15FD14937016AEFE50009F9</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.21983</idno><idno type="url">https://api.istex.fr/document/410C307BA276A22DA15FD14937016AEFE50009F9/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001215</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Susceptibility genes in movement disorders</title><author><name sortKey="Scholz, Sonja" sort="Scholz, Sonja" uniqKey="Scholz S" first="Sonja" last="Scholz">Sonja Scholz</name><affiliation><mods:affiliation>Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square House, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Singleton, Andrew" sort="Singleton, Andrew" uniqKey="Singleton A" first="Andrew" last="Singleton">Andrew Singleton</name><affiliation><mods:affiliation>Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-05-15">2008-05-15</date><biblScope unit="vol">23</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="927">927</biblScope><biblScope unit="page" to="934">934</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">410C307BA276A22DA15FD14937016AEFE50009F9</idno><idno type="DOI">10.1002/mds.21983</idno><idno type="ArticleID">MDS21983</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>candidate gene</term><term>linkage study</term><term>movement disorder</term><term>susceptibility gene</term><term>whole genome association study</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">During the last years, remarkable progress in our understanding of molecular genetic mechanisms underlying movement disorders has been achieved. The successes of linkage studies, followed by positional cloning, have dominated the last decade and several genes underlying monogenic disorders have been discovered. The pathobiological understanding garnered from these mutations has laid the foundation for much of the search for genetic loci that confer risk for, rather than cause, disease. With the introduction of whole genome association studies as a novel tool to investigate genetic variation underlying common, complex diseases, a new era in neurogenomics has just begun. As the field rapidly moves forward several new challenges and critical questions in clinical care have to be addressed. In this review, we summarize recent advances in the discovery of susceptibility loci underlying major movement disorders, explain the newest methodologies and tools employed for finding and characterizing genes and discuss how insights into the molecular genetic basis of neurological disorders will impact therapeutic concepts in patient care. © 2008 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Sonja Scholz MD</name><affiliations><json:string>Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA</json:string><json:string>Department of Molecular Neuroscience, Institute of Neurology, Queen Square House, London, United Kingdom</json:string></affiliations></json:item><json:item><name>Andrew Singleton PhD</name><affiliations><json:string>Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>movement disorder</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>susceptibility gene</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>linkage study</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>candidate gene</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>whole genome association study</value></json:item></subject><language><json:string>eng</json:string></language><abstract>During the last years, remarkable progress in our understanding of molecular genetic mechanisms underlying movement disorders has been achieved. The successes of linkage studies, followed by positional cloning, have dominated the last decade and several genes underlying monogenic disorders have been discovered. The pathobiological understanding garnered from these mutations has laid the foundation for much of the search for genetic loci that confer risk for, rather than cause, disease. With the introduction of whole genome association studies as a novel tool to investigate genetic variation underlying common, complex diseases, a new era in neurogenomics has just begun. As the field rapidly moves forward several new challenges and critical questions in clinical care have to be addressed. In this review, we summarize recent advances in the discovery of susceptibility loci underlying major movement disorders, explain the newest methodologies and tools employed for finding and characterizing genes and discuss how insights into the molecular genetic basis of neurological disorders will impact therapeutic concepts in patient care. © 2008 Movement Disorder Society</abstract><qualityIndicators><score>6.465</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1175</abstractCharCount><pdfWordCount>4437</pdfWordCount><pdfCharCount>31554</pdfCharCount><pdfPageCount>8</pdfPageCount><abstractWordCount>169</abstractWordCount></qualityIndicators><title>Susceptibility genes in movement disorders</title><genre><json:string>Serial article</json:string></genre><host><volume>23</volume><pages><total>8</total><last>934</last><first>927</first></pages><issn><json:string>0885-3185</json:string></issn><issue>7</issue><subject><json:item><value>Review</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2008</publicationDate><copyrightDate>2008</copyrightDate><doi><json:string>10.1002/mds.21983</json:string></doi><id>410C307BA276A22DA15FD14937016AEFE50009F9</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/410C307BA276A22DA15FD14937016AEFE50009F9/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/410C307BA276A22DA15FD14937016AEFE50009F9/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/410C307BA276A22DA15FD14937016AEFE50009F9/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Susceptibility genes in movement disorders</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>2008</date></publicationStmt><notesStmt><note>National Institute on Aging</note><note>National Institutes of Health</note><note>Department of Health and Human Services</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Susceptibility genes in movement disorders</title><author><persName><forename type="first">Sonja</forename><surname>Scholz</surname><roleName type="degree">MD</roleName></persName><affiliation>Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA</affiliation><affiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square House, London, United Kingdom</affiliation></author><author><persName><forename type="first">Andrew</forename><surname>Singleton</surname><roleName type="degree">PhD</roleName></persName><note type="correspondence"><p>Correspondence: Laboratory of Neurogenetics, 35 Convent drive, Room 1A‐1015, 20892 Bethesda, MD, USA</p></note><affiliation>Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-05-15"></date><biblScope unit="vol">23</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="927">927</biblScope><biblScope unit="page" to="934">934</biblScope></imprint></monogr><idno type="istex">410C307BA276A22DA15FD14937016AEFE50009F9</idno><idno type="DOI">10.1002/mds.21983</idno><idno type="ArticleID">MDS21983</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2008</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>During the last years, remarkable progress in our understanding of molecular genetic mechanisms underlying movement disorders has been achieved. The successes of linkage studies, followed by positional cloning, have dominated the last decade and several genes underlying monogenic disorders have been discovered. The pathobiological understanding garnered from these mutations has laid the foundation for much of the search for genetic loci that confer risk for, rather than cause, disease. With the introduction of whole genome association studies as a novel tool to investigate genetic variation underlying common, complex diseases, a new era in neurogenomics has just begun. As the field rapidly moves forward several new challenges and critical questions in clinical care have to be addressed. In this review, we summarize recent advances in the discovery of susceptibility loci underlying major movement disorders, explain the newest methodologies and tools employed for finding and characterizing genes and discuss how insights into the molecular genetic basis of neurological disorders will impact therapeutic concepts in patient care. © 2008 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>movement disorder</term></item><item><term>susceptibility gene</term></item><item><term>linkage study</term></item><item><term>candidate gene</term></item><item><term>whole genome association study</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Review</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2007-11-05">Received</change><change when="2008-01-19">Registration</change><change when="2008-05-15">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/410C307BA276A22DA15FD14937016AEFE50009F9/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="70"><doi origin="wiley" registered="yes">10.1002/mds.v23:7</doi><numberingGroup><numbering type="journalVolume" number="23">23</numbering><numbering type="journalIssue">7</numbering></numberingGroup><coverDate startDate="2008-05-15">15 May 2008</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="10" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.21983</doi><idGroup><id type="unit" value="MDS21983"></id></idGroup><countGroup><count type="pageTotal" number="8"></count></countGroup><titleGroup><title type="articleCategory">Review</title><title type="tocHeading1">Reviews</title></titleGroup><copyright ownership="thirdParty">Copyright © 2008 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2007-11-05"></event><event type="manuscriptRevised" date="2008-01-15"></event><event type="manuscriptAccepted" date="2008-01-19"></event><event type="publishedOnlineEarlyUnpaginated" date="2008-02-29"></event><event type="firstOnline" date="2008-02-29"></event><event type="publishedOnlineFinalForm" date="2008-05-28"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.6 mode:FullText source:FullText result:FullText" date="2010-04-21"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">927</numbering><numbering type="pageLast">934</numbering></numberingGroup><correspondenceTo>Laboratory of Neurogenetics, 35 Convent drive, Room 1A‐1015, 20892 Bethesda, MD, USA</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS21983.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="1"></count><count type="referenceTotal" number="44"></count><count type="wordTotal" number="5909"></count></countGroup><titleGroup><title type="main" xml:lang="en">Susceptibility genes in movement disorders</title><title type="short" xml:lang="en">Susceptibility Genes in Movement Disorders</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1 #af2"><personName><givenNames>Sonja</givenNames><familyName>Scholz</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Andrew</givenNames><familyName>Singleton</familyName><degrees>PhD</degrees></personName><contactDetails><email>singleta@mail.nih.gov</email></contactDetails></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="GB" type="organization"><unparsedAffiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square House, London, United Kingdom</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">movement disorder</keyword><keyword xml:id="kwd2">susceptibility gene</keyword><keyword xml:id="kwd3">linkage study</keyword><keyword xml:id="kwd4">candidate gene</keyword><keyword xml:id="kwd5">whole genome association study</keyword></keywordGroup><fundingInfo><fundingAgency>National Institute on Aging</fundingAgency></fundingInfo><fundingInfo><fundingAgency>National Institutes of Health</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Department of Health and Human Services</fundingAgency></fundingInfo><supportingInformation><p> This article is part of the journal's CME program. The CME form can be found on page 1064 and is available online at <url href="http://www.movementdisorders.org/education/activities.html"> http://www.movementdisorders.org/education/activities.html </url></p></supportingInformation><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>During the last years, remarkable progress in our understanding of molecular genetic mechanisms underlying movement disorders has been achieved. The successes of linkage studies, followed by positional cloning, have dominated the last decade and several genes underlying monogenic disorders have been discovered. The pathobiological understanding garnered from these mutations has laid the foundation for much of the search for genetic loci that confer risk for, rather than cause, disease. With the introduction of whole genome association studies as a novel tool to investigate genetic variation underlying common, complex diseases, a new era in neurogenomics has just begun. As the field rapidly moves forward several new challenges and critical questions in clinical care have to be addressed. In this review, we summarize recent advances in the discovery of susceptibility loci underlying major movement disorders, explain the newest methodologies and tools employed for finding and characterizing genes and discuss how insights into the molecular genetic basis of neurological disorders will impact therapeutic concepts in patient care. © 2008 Movement Disorder Society</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Susceptibility genes in movement disorders</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Susceptibility Genes in Movement Disorders</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Susceptibility genes in movement disorders</title></titleInfo><name type="personal"><namePart type="given">Sonja</namePart><namePart type="family">Scholz</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA</affiliation><affiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square House, London, United Kingdom</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Andrew</namePart><namePart type="family">Singleton</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA</affiliation><description>Correspondence: Laboratory of Neurogenetics, 35 Convent drive, Room 1A‐1015, 20892 Bethesda, MD, USA</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">reviewArticle</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2008-05-15</dateIssued><dateCaptured encoding="w3cdtf">2007-11-05</dateCaptured><dateValid encoding="w3cdtf">2008-01-19</dateValid><copyrightDate encoding="w3cdtf">2008</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">1</extent><extent unit="references">44</extent><extent unit="words">5909</extent></physicalDescription><abstract lang="en">During the last years, remarkable progress in our understanding of molecular genetic mechanisms underlying movement disorders has been achieved. The successes of linkage studies, followed by positional cloning, have dominated the last decade and several genes underlying monogenic disorders have been discovered. The pathobiological understanding garnered from these mutations has laid the foundation for much of the search for genetic loci that confer risk for, rather than cause, disease. With the introduction of whole genome association studies as a novel tool to investigate genetic variation underlying common, complex diseases, a new era in neurogenomics has just begun. As the field rapidly moves forward several new challenges and critical questions in clinical care have to be addressed. In this review, we summarize recent advances in the discovery of susceptibility loci underlying major movement disorders, explain the newest methodologies and tools employed for finding and characterizing genes and discuss how insights into the molecular genetic basis of neurological disorders will impact therapeutic concepts in patient care. © 2008 Movement Disorder Society</abstract><note type="funding">National Institute on Aging</note><note type="funding">National Institutes of Health</note><note type="funding">Department of Health and Human Services</note><subject lang="en"><genre>Keywords</genre><topic>movement disorder</topic><topic>susceptibility gene</topic><topic>linkage study</topic><topic>candidate gene</topic><topic>whole genome association study</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><note type="content"> This article is part of the journal's CME program. The CME form can be found on page 1064 and is available online at http://www.movementdisorders.org/education/activities.html</note><subject><genre>article category</genre><topic>Review</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><detail type="issue"><caption>no.</caption><number>7</number></detail><extent unit="pages"><start>927</start><end>934</end><total>8</total></extent></part></relatedItem><identifier type="istex">410C307BA276A22DA15FD14937016AEFE50009F9</identifier><identifier type="DOI">10.1002/mds.21983</identifier><identifier type="ArticleID">MDS21983</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2008 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001215 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001215 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:410C307BA276A22DA15FD14937016AEFE50009F9
|texte= Susceptibility genes in movement disorders
}}
| This area was generated with Dilib version V0.6.23. |  |